๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A Fortran program for the design and analysis of sequential clinical trials

โœ Scribed by John Whitehead; Patrick Marek


Publisher
Elsevier Science
Year
1985
Tongue
English
Weight
473 KB
Volume
18
Category
Article
ISSN
0010-4809

No coin nor oath required. For personal study only.

โœฆ Synopsis


Clinical scientists are becoming increasingly aware of the need to monitor clinical trials in progress, and to validate their procedure by the use of a formal sequential design. An interactive program, written in FORTRAN 77 and called "PEST: Planning and Evaluation of Sequential Tests," is introduced. The program can be used to design trials based on the sequential probability ratio test, the triangular test, and the restricted procedure, among others. Furthermore, from the observed terminal values of the test statistics, the program will provide an analysis which includes the significance level and point and interval estimates of the parameter of interest. The computations are based on large-sample theory which encompasses many types of patient response, including binary and ordinal outcomes as well as SUITiVal times.


๐Ÿ“œ SIMILAR VOLUMES


A Microcomputer Program for the Design a
โœ E. Bellissant; J. Benichou; Cl. Chastang ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 470 KB

We developed an interactive and menu-driven computer program to help investigators design and analyze phase II cancer clinical trials with a group sequential method, namely the sequential probability ratio test or the triangular test. Based on the values selected for the parameters of the trial, the

A Fortran program for fast and compact p
โœ I.P. Coles; R.G. Dale ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 456 KB

## A set of Fortran IV programs have been developed to enable a patient registry to operate on a minicomputer of a type frequently used for treatment planning within radiotherapy departments. The system is both comprehensive and flexible, allowing the efficient storage of clinical data in the form

META-ANALYSIS IN THE DESIGN AND MONITORI
โœ REBECCA DERSIMONIAN ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 828 KB

Results from external studies often play an important role in many aspects of a clinical trial. Their incorporation into the decision making process of a trial, however, is rarely conducted in a formal manner. This conference will address what formal role, if any, meta-analytic summaries of external

Time for changes in the design, analysis
โœ David T. Felson; Jennifer J. Anderson; Robert F. Meenan ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 910 KB

The randomized, controlled clinical trial has become the standard approach to evaluating the efficacy of slow-acting drugs in the treatment of rheumatoid arthritis (RA). Such trials, which were used as far back as the 1940s to evaluate antimalarial agents and gold and as recently as 1988 to evaluate